首页
>>
产品中心
>>
抗体产品
>>
重组抗体
>
Anti-Human ANGPT2 & VEGFA Recombinant Antibody(Vanucizumab)

Anti-Human ANGPT2 & VEGFA Recombinant Antibody(Vanucizumab)

产品编号

YR1341

别名

科研级 Vanucizumab ( 伐努赛珠单抗 ), Anti-ANGPT2 & VEGFA Recombinant Antibody, Research Grade Vanucizumab

规格
  • 1mg
  • 5mg
产品介绍
Alias科研级 Vanucizumab ( 伐努赛珠单抗 ), Anti-ANGPT2 & VEGFA Recombinant Antibody, Research Grade Vanucizumab
Catalog NumberYR1341
Molecular NameVanucizumab
Size1mg, 5mg
ClonityMonoclonal
Purity>95% as determined by SDS-PAGE
Concentration1mg/ml
Antibody IsotypeVH-C Kappa-CH2-CH3_V Lambda-CH1_H-GAMMA-1_L Kappa
FormulationPBS, pH7.5
BackgroundVanucizumab (INN, development code RG7221) is an experimental humanized monoclonal antibody designed for the treatment of cancer.
CAS Number1448221-05-3
ApplicationWB, FCM, IP, ELISA, Neut, FuncS, IF
Storage ConditionIt is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
RemarksThis product is for research use only.
Shipping ConditionShipped on ice packs.
TargetANGPT2 & VEGFA[Homo sapiens],

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价